Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 7.55 is in line with its 5-year average of 8.06, near the low end of its 5-year range (5.68–15.13).
As of the fiscal period ended Tuesday, June 30, 2026. 2.82% above its 12-month average of 7.34.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.55.
QUICK RATIO (ACID-TEST)
7.55
QUICK RATIO (ACID-TEST) AVG TTM
7.34
QUICK RATIO (ACID-TEST) AVG 3Y
7.72
QUICK RATIO (ACID-TEST) AVG 5Y
8.06
QUICK RATIO (ACID-TEST) AVG 10Y
8.71
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+2.82%
CURRENT VS 3Y AVG
-2.17%
CURRENT VS 5Y AVG
-6.35%
CURRENT VS 10Y AVG
-13.35%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+125.04%
vs the sector median at left
SI-BONE, Inc.
Market Cap
$867.03M
Quick Ratio (Acid-Test)
7.55
TTM Avg
7.34
3Y Avg
7.72
5Y Avg
8.06
Market Cap
$870.81M
Quick Ratio (Acid-Test)
11.36
TTM Avg
7.20
3Y Avg
7.20
5Y Avg
7.20
Market Cap
$857.16M
Quick Ratio (Acid-Test)
0.76
TTM Avg
0.79
3Y Avg
0.88
5Y Avg
1.73
Market Cap
$853.13M
Quick Ratio (Acid-Test)
1.79
TTM Avg
2.17
3Y Avg
1.93
5Y Avg
2.04
Market Cap
$852.35M
Quick Ratio (Acid-Test)
3.05
TTM Avg
34.00
3Y Avg
26.34
5Y Avg
26.34
Market Cap
$884.97M
Quick Ratio (Acid-Test)
81.42
TTM Avg
11.94
3Y Avg
8.59
5Y Avg
10.34
Market Cap
$887.50M
Quick Ratio (Acid-Test)
1.17
TTM Avg
1.03
3Y Avg
0.92
5Y Avg
1.05
Market Cap
$887.99M
Quick Ratio (Acid-Test)
16.16
TTM Avg
3.88
3Y Avg
3.97
5Y Avg
4.50
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SI-BONE, Inc. (SIBN) | $867.03M | 7.55 | 7.34 | 7.72 | 8.06 |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $870.81M | 11.36 | 7.20 | 7.20 | 7.20 |
| QuidelOrtho Corporation (QDEL)vs › | $857.16M | 0.76 | 0.79 | 0.88 | 1.73 |
| Alumis Inc. (ALMS)vs › | $855.38M | 6.74 | 5.17 | 5.15 | 5.15 |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $853.13M | 1.79 | 2.17 | 1.93 | 2.04 |
| SL Science Holding Ltd (SLBT)vs › | $852.35M | 3.05 | 34.00 | 26.34 | 26.34 |
| Arbutus Biopharma Corp (ABUS)vs › | $884.97M | 81.42 | 11.94 | 8.59 | 10.34 |
| Bioventus Inc. (BVS)vs › | $887.50M | 1.17 | 1.03 | 0.92 | 1.05 |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $887.99M | 16.16 | 3.88 | 3.97 | 4.50 |
| Pacific Biosciences of California, Inc. (PACB)vs › | $838.62M | 4.03 | 6.29 | 5.71 | 7.79 |
Quick Ratio
7.55
Excludes inventory
Current Ratio
9.15
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 7.55 |
| 2026-03-31 | 8.34 |
| 2025-12-31 | 7.21 |
| 2025-09-30 | 6.62 |
| 2025-06-30 | 7.00 |
| 2025-03-31 | 7.26 |
| 2024-12-31 | 6.66 |
| 2024-09-30 | 7.22 |
| 2024-06-30 | 8.12 |
| 2024-03-31 | 8.75 |
| 2023-12-31 | 8.15 |
| 2023-09-30 | 9.74 |
| 2023-06-30 | 10.55 |
| 2023-03-31 | 6.65 |
| 2022-12-31 | 5.68 |
| 2022-09-30 | 6.59 |
| 2022-06-30 | 7.91 |
| 2022-03-31 | 9.48 |
| 2021-12-31 | 9.73 |
| 2021-09-30 | 12.04 |
| 2021-06-30 | 15.13 |
| 2021-03-31 | 14.64 |
| 2020-12-31 | 15.78 |
| 2020-09-30 | 12.22 |
| 2020-06-30 | 12.75 |
| 2020-03-31 | 7.59 |
| 2019-12-31 | 5.65 |
| 2019-09-30 | 8.40 |
| 2019-06-30 | 11.55 |
| 2019-03-31 | 12.70 |
| 2018-12-31 | 14.73 |
| 2018-09-30 | 2.44 |
| 2018-06-30 | 3.36 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 4.12 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 2.66 |
| 2016-03-31 | 0.00 |
| 2015-03-31 | 2.60 |
| 2014-12-31 | 3.50 |
| 2014-03-31 | 0.00 |
